Ilan Oren - Jul 23, 2024 Form 4 Insider Report for Roivant Sciences Ltd. (ROIV)

Role
Director
Signature
By: /s/ Jo Chen, as Attorney-in-Fact for Ilan Oren
Stock symbol
ROIV
Transactions as of
Jul 23, 2024
Transactions value $
-$2,367
Form type
4
Date filed
7/25/2024, 09:00 PM
Previous filing
Apr 26, 2024
Next filing
Sep 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ROIV Common Shares Award $0 +2.44K +3.03% $0.00 82.8K Jul 23, 2024 Direct F1
transaction ROIV Common Shares Tax liability -$2.37K -215 -0.26% $11.01 82.6K Jul 23, 2024 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects an award of Common Shares received pursuant to the Company's Non-Employee Director Compensation Plan that was fully vested as of the grant date.
F2 Represents the "net settlement" by the Issuer of Common Shares previously granted to the reporting person pursuant to the Issuer's Non-Employee Director Compensation Plan in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such Common Shares.